
Canada - TSX:NEPT - CA64079L2049 - Common Stock
The current stock price of NEPT.CA is 1.97 CAD. In the past month the price increased by 10.06%. In the past year, price decreased by -92.78%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| JWEL.CA | JAMIESON WELLNESS INC | 21.69 | 1.46B | ||
| LOVE.CA | CANNARA BIOTECH INC | 9.47 | 152.79M | ||
| VPI.CA | VITALITY PRODUCTS INC | N/A | 1.24M |
Neptune Wellness Solutions Inc is a CA-based company operating in Personal Products industry. The company is headquartered in Laval, Quebec and currently employs 161 full-time employees. The company went IPO on 2001-07-11. Neptune Wellness Solutions Inc. (Neptune) is a diversified and fully integrated health and wellness company. The firm is focused on building a portfolio of natural, plant-based consumer products. Neptune is a provider of turnkey product development and supply chain solutions to business customers across various health and wellness verticals, including legal cannabis and hemp, nutraceuticals and consumer packaged goods. The firm is engaged in cannabis and hemp operation with research, development and commercialization focused on the use of cannabinoids in household products. Its consumer brands include the Forest Remedies and Ocean Remedies brands. Under the Forest Remedies brand, Neptune offers a full line of health and wellness products with and without cannabidiol. The Ocean Remedies brand offers consumers a source of omega-3 supplements. Ocean Remedies krill oil offers high eicosapentaenoic acid, docosahexaenoic acid, phospholipid levels and astaxanthin, a natural antioxidant.
Neptune Wellness Solutions Inc
100-545 Promenade du Centropolis
LAVAL QUEBEC H7T 0A3 CA
CEO: Michael Cammarata
Employees: 161
Phone: 14506872262.0
Neptune Wellness Solutions Inc is a CA-based company operating in Personal Products industry. The company is headquartered in Laval, Quebec and currently employs 161 full-time employees. The company went IPO on 2001-07-11. Neptune Wellness Solutions Inc. (Neptune) is a diversified and fully integrated health and wellness company. The firm is focused on building a portfolio of natural, plant-based consumer products. Neptune is a provider of turnkey product development and supply chain solutions to business customers across various health and wellness verticals, including legal cannabis and hemp, nutraceuticals and consumer packaged goods. The firm is engaged in cannabis and hemp operation with research, development and commercialization focused on the use of cannabinoids in household products. Its consumer brands include the Forest Remedies and Ocean Remedies brands. Under the Forest Remedies brand, Neptune offers a full line of health and wellness products with and without cannabidiol. The Ocean Remedies brand offers consumers a source of omega-3 supplements. Ocean Remedies krill oil offers high eicosapentaenoic acid, docosahexaenoic acid, phospholipid levels and astaxanthin, a natural antioxidant.
The current stock price of NEPT.CA is 1.97 CAD. The price decreased by -3.43% in the last trading session.
NEPT.CA does not pay a dividend.
NEPT.CA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
NEPT.CA stock is listed on the Toronto Stock Exchange exchange.
Neptune Wellness Solutions Inc (NEPT.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-260.46).
You can find the ownership structure of Neptune Wellness Solutions Inc (NEPT.CA) on the Ownership tab.
ChartMill assigns a technical rating of 1 / 10 to NEPT.CA. When comparing the yearly performance of all stocks, NEPT.CA is a bad performer in the overall market: 99.66% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to NEPT.CA. NEPT.CA may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months NEPT.CA reported a non-GAAP Earnings per Share(EPS) of -260.46. The EPS decreased by -453.14% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -154.23% | ||
| ROA | -70.97% | ||
| ROE | N/A | ||
| Debt/Equity | 0.24 |
10 analysts have analysed NEPT.CA and the average price target is 26.78 CAD. This implies a price increase of 1259.14% is expected in the next year compared to the current price of 1.97.
For the next year, analysts expect an EPS growth of 99.09% and a revenue growth 56.09% for NEPT.CA